News & Blogs

Steve Forbes: Democrats’ drug-pricing plan warrants disinformation flag for seniors

Senate Democrats are moving forward with a falsely advertised drug pricing plan. Liberals, and even maverick Sen. Joe Manchin (D-W.Va.), claim their newest plan will help lower drug costs for seniors and even drive down inflation. As always, however, the fine print says something else. In fact, the scheme would be a disaster for the development of life-extending, life-improving medicines and medical devices. Start with the money. The details show their proposal is more about…

Learn More

American Commitment to Seniors Launches Seven-Figure Ad Buy Slamming Washington Liberals’ Plan To Slash Medicare Prescription Drug Spending

Ad Highlights How Democrats’ Drug Pricing Proposal Would Harm Seniors and Raid Nearly $300 Billion From Medicare. CONTACT: Jon Decker (jon@americancommitment.org) WASHINGTON, D.C. (July 28, 2022) — American Commitment’s Commitment to Seniors project has launched a new seven-figure initial ad buy, raising concerns about Washington liberals’ claim that their partisan spending bill “lowers seniors’ drug costs,” when actually, it siphons nearly $300 billion out of Medicare to unrelated spending. The ad is airing through August 5…

Learn More

Media Advisory: Senate Democrats and AARP Have Opportunity to Answer Critical Questions on Partisan Drug Pricing Proposal

***Media Advisory – Today: Capitol Hill Conference on Drug Pricing Proposal*** Senate Democrats and AARP Have Opportunity to Answer Critical Questions on Partisan Drug Pricing Proposal WASHINGTON – [7/27/22] — Today, Wednesday, July 27 at 3:00 p.m. EST, AARP CEO Jo Ann Jenkins and other advocates will join Senate Democrats at a press conference to discuss the partisan drug pricing proposal that will be voted on in the U.S. Senate in the coming days. Considering…

Learn More

Jon Decker: AARP’s support for Medicare “negotiation” not in seniors’ interest

In a recent op-ed discussing health care and inflation, AARP’s West Virginia chapter called for a Medicare “negotiation” scheme to address prescription drug prices. This tired proposal would be disastrous for pharmaceutical innovation – and, ultimately, for the seniors the AARP claims to represent. Medicare negotiation is tantamount to government-imposed price controls, forcing manufacturers to set prices on certain medications at the government’s direction or face a 95 percent excise tax. And while the AARP…

Learn More